Durac, Beverlyn B.

HRN: 11-42-17  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2025
CEFTRIAXONE 1G (VIAL)
09/30/2025
10/06/2025
IV
2 G
OD
Ovarian Torsion, For Pelvic Lap
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: